Published in Arch Dermatol Res on January 01, 1995
Molecular therapies for systemic lupus erythematosus: clinical trials and future prospects. Arthritis Res Ther (2009) 0.91
Topical tacrolimus and pimecrolimus in the treatment of cutaneous lupus erythematosus: an evidence-based evaluation. Eur J Clin Pharmacol (2007) 0.86
FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70
FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J Antibiot (Tokyo) (1987) 4.54
The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol (1992) 3.66
The genetic contribution of the NZB mouse to the renal disease of the NZB x NZW hybrid. Clin Exp Immunol (1977) 2.00
Dermatopathological studies on skin lesions of MRL mice. Arch Dermatol Res (1984) 1.62
CS-A therapy in MRL-lpr/lpr mice: amelioration of immunopathology despite autoantibody production. J Immunol (1987) 1.38
Tacrolimus (FK 506)--a new therapeutic agent for severe recalcitrant psoriasis. Arch Dermatol (1992) 1.32
Effect of FK-506, a novel immunosuppressive drug on murine systemic lupus erythematosus. Clin Immunol Immunopathol (1989) 1.03
Ultrastructural observations of skin lesions in MRL mice--dermoepidermal junction. Arch Dermatol Res (1984) 1.01
Enzyme-linked immunosorbent assay for antibodies to native DNA in sera of patients with SLE. J Immunol Methods (1982) 0.99
Characterization of cutaneous infiltrates in MRL/lpr mice monitored from onset to the full development of lupus erythematosus-like skin lesions. J Invest Dermatol (1991) 0.96
Immunosuppressive macrolides of the type FK 506: a novel class of topical agents for treatment of skin diseases? J Invest Dermatol (1992) 0.92
Effects of FK-506 on collagen arthritis in mice. Transplant Proc (1989) 0.91
Experimental treatment of autoimmune MRL-lpr/lpr mice with immunosuppressive compound FK506. Immunology (1990) 0.90
Histamine metabolism in skin of MRL/l mice. Arch Dermatol Res (1985) 0.89
Ultrastructural lupus band test in the skin of MRL mice. Arch Dermatol Res (1986) 0.86
Anti-inflammatory effect of FK-506 on human skin mast cells. J Invest Dermatol (1992) 0.86
Stimulation of hair growth by topical application of FK506, a potent immunosuppressive agent. J Invest Dermatol (1994) 0.86
Effects of cyclosporin A on autoimmune disease in MRL/1 and BXSB mice. Scand J Immunol (1986) 0.85
FK 506 and autoimmune disease: perspective and prospects. Autoimmunity (1992) 0.85
Efficacy of FK 506 in the treatment of recalcitrant pyoderma gangrenosum. Transplant Proc (1991) 0.85
Pathogenesis of lupus dermatoses in autoimmune mice. X. Evaluation of histamine-N-methyltransferase activity in the skin of autoimmune. Microbiol Immunol (1988) 0.82
FK506: the promise and the paradox. Clin Exp Immunol (1991) 0.79
Pathogenesis of lupus dermatoses in autoimmune mice. XIX. Attempts to induce subepidermal immunoglobulin deposition in MRL/Mp- +/+ mice. Arch Dermatol Res (1993) 0.78
Evaluation of the Japanese-Chinese herbal medicine, kampo, for the treatment of lupus dermatoses in autoimmune prone MRL/Mp-lpr/lpr mice. J Dermatol (1994) 0.78
Ultrastructural observations of skin lesions in MRL mice--dermal infiltrations and capillary changes. J Dermatol (1986) 0.77
High levels of anti-mitochondrial antibodies in MRL mice. Influence of anti-DNA antibodies on anti-mitochondrial antibodies measured by an enzyme-linked immunosorbent assay. Microbiol Immunol (1987) 0.77
CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. J Exp Med (1996) 3.82
TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells). J Immunol (1985) 3.18
Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: A mouse fibrosis model. J Cell Physiol (1999) 2.77
Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo. J Biochem (1999) 2.18
Proposal for a unified CCN nomenclature. Mol Pathol (2003) 1.98
High frequency class switching of an IgM+ B lymphoma clone CH12F3 to IgA+ cells. Int Immunol (1996) 1.97
Fractalkine and macrophage-derived chemokine: T cell-attracting chemokines expressed in T cell area dendritic cells. Eur J Immunol (1999) 1.82
A case of Rothmund-Thomson syndrome with reduced DNA repair capacity. Arch Dermatol (1993) 1.76
Developmentally regulated expression of the PD-1 protein on the surface of double-negative (CD4-CD8-) thymocytes. Int Immunol (1996) 1.68
The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells. J Exp Med (1996) 1.59
Spontaneous autoimmune skin lesions of MRL/n mice: autoimmune disease-prone genetic background in relation to Fas-defect MRL/1pr mice. J Invest Dermatol (1996) 1.57
Are nonfunctioning pituitary adenomas extending into the cavernous sinus aggressive and/or invasive? Neurosurgery (2001) 1.57
Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species. Gut (1987) 1.57
Effects of CTGF/Hcs24, a product of a hypertrophic chondrocyte-specific gene, on the proliferation and differentiation of chondrocytes in culture. Endocrinology (2000) 1.57
Purification and characterization of choline oxidase from Arthrobacter globiformis. J Biochem (1977) 1.55
ADP-ribosylation of the rhoA gene product by botulinum C3 exoenzyme causes Swiss 3T3 cells to accumulate in the G1 phase of the cell cycle. Oncogene (1993) 1.55
Effects of CTGF/Hcs24, a hypertrophic chondrocyte-specific gene product, on the proliferation and differentiation of osteoblastic cells in vitro. J Cell Physiol (2000) 1.51
A monoclonal antibody specifically reactive to human Langerhans cells. J Invest Dermatol (1986) 1.48
Kinetics of fetal cellular and cell-free DNA in the maternal circulation during and after pregnancy: implications for noninvasive prenatal diagnosis. Transfusion (2001) 1.46
Oxidative pathway of choline to betaine in the soluble fraction prepared from Arthrobacter globiformis. J Biochem (1977) 1.44
Mosaic expression of uncein and 180-kDa bullous pemphigoid antigen in generalized atrophic benign epidermolysis bullosa. Br J Dermatol (1997) 1.42
Novel mechanism associated with an inherited cardiac arrhythmia: defective protein trafficking by the mutant HERG (G601S) potassium channel. Circulation (1999) 1.42
Gender of demented patients and specific family relationship of caregiver to patients influence mental fatigue and burdens on relatives as caregivers. Int J Geriatr Psychiatry (1999) 1.40
Studies on indirect hemagglutination test for leptospirosis. Jpn J Exp Med (1972) 1.40
Peripheral blood stem cell collection and transplantation using the Haemonetics Multi Component System. Transfus Sci (1999) 1.39
I-123 iomazenil SPECT in patients with mental disorders. Ann Nucl Med (1997) 1.39
Immunohistochemically detectable duct-like structures in benign and malignant eccrine poromas: CEA and involucrin immunostaining. J Dermatol (1989) 1.39
Plane warts under spontaneous regression. Immunopathologic study on cellular constituents leading to the inflammatory reaction. Arch Dermatol (1986) 1.39
Effect of antibiotics on the generation of reactive oxygen species. J Invest Dermatol (1986) 1.38
Purification of Streptomyces chromofuscus phospholipase D by hydrophobic affinity chromatography on palmitoyl cellulose. J Biochem (1979) 1.38
Mosaic pattern of dystrophins in Duchenne muscular dystrophy. Pediatr Neurol (1990) 1.38
Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis. J Rheumatol (2000) 1.38
Cloning of a mRNA preferentially expressed in chondrocytes by differential display-PCR from a human chondrocytic cell line that is identical with connective tissue growth factor (CTGF) mRNA. Biochem Biophys Res Commun (1997) 1.37
Interleukin-10 expressed at early tumour sites induces subsequent generation of CD4(+) T-regulatory cells and systemic collapse of antitumour immunity. Immunology (2001) 1.30
"Abacterial" and bacterial pyelonephritis. Immunofluorescent localization of bacterial antigen. N Engl J Med (1969) 1.28
Type II alveolar epithelial cells and interstitial fibroblasts express connective tissue growth factor in IPF. Eur Respir J (2001) 1.25
Collagenase-3 (MMP-13) expression in chondrosarcoma cells and its regulation by basic fibroblast growth factor. Am J Pathol (1998) 1.24
Amyloidosis cutis dyschromica. DNA repair reduction in the cellular response to UV light. Arch Dermatol (1992) 1.24
Glucose-sensitive neurons in the rat arcuate nucleus contain neuropeptide Y. Neurosci Lett (1999) 1.23
Increased expression of connective tissue growth factor in the infarct zone of experimentally induced myocardial infarction in rats. J Mol Cell Cardiol (1998) 1.23
The two functional keratin 6 genes of mouse are differentially regulated and evolved independently from their human orthologs. Genomics (1998) 1.23
E- and P-cadherin expression during murine hair follicle morphogenesis and cycling. Exp Dermatol (1999) 1.22
CTGF/Hcs24 induces chondrocyte differentiation through a p38 mitogen-activated protein kinase (p38MAPK), and proliferation through a p44/42 MAPK/extracellular-signal regulated kinase (ERK). Eur J Biochem (2001) 1.21
The role of oxidative DNA damage in human arsenic carcinogenesis: detection of 8-hydroxy-2'-deoxyguanosine in arsenic-related Bowen's disease. J Invest Dermatol (1999) 1.20
Confirmation that the conotruncal anomaly face syndrome is associated with a deletion within 22q11.2. Am J Med Genet (1994) 1.19
Expression of connective tissue growth factor in cartilaginous tumors. Cancer (2000) 1.19
Hypersensitivity to mosquito bites as the primary clinical manifestation of a juvenile type of Epstein-Barr virus-associated natural killer cell leukemia/lymphoma. J Am Acad Dermatol (2001) 1.17
Human cutaneous dendritic cells migrate through dermal lymphatic vessels in a skin organ culture model. J Invest Dermatol (1996) 1.15
Molecular and clinical study of 183 patients with conotruncal anomaly face syndrome. Hum Genet (1998) 1.15
Overexpression of connective tissue growth factor/hypertrophic chondrocyte-specific gene product 24 decreases bone density in adult mice and induces dwarfism. Biochem Biophys Res Commun (2001) 1.15
Enhancement of calcium sensitivity of lipocortin I in phospholipid binding induced by limited proteolysis and phosphorylation at the amino terminus as analyzed by phospholipid affinity column chromatography. J Biol Chem (1989) 1.15
Nitric oxide mediates interleukin-1-induced gene expression of matrix metalloproteinases and basic fibroblast growth factor in cultured rabbit articular chondrocytes. J Biochem (1998) 1.14
Subcellular distribution of tight junction-associated proteins (occludin, ZO-1, ZO-2) in rodent skin. J Invest Dermatol (1998) 1.13
Regression of plane warts following spontaneous inflammation. An histopathological study. Br J Dermatol (1974) 1.13
Cyclic mechanical stress induces extracellular matrix degradation in cultured chondrocytes via gene expression of matrix metalloproteinases and interleukin-1. J Biochem (1999) 1.13
8-hydroxy-2'-deoxyguanosine is increased in epidermal cells of hairless mice after chronic ultraviolet B exposure. J Invest Dermatol (1996) 1.13
Effect of DL-alpha-hydrazino-delta-aminovaleric acid, an inhibitor of ornithine decarboxylase, on polyamine metabolism in isoproterenol-stimulated mouse parotid glands. J Biochem (1975) 1.12
Treatment of acute febrile neutrophilic dermatosis (Sweet's Syndrome) with potassium iodide. Dermatologica (1980) 1.11
Penis tuberculides: papulonecrotic tuberculides on the glans penis. Dermatologica (1986) 1.11
Histological diagnostic criteria for accessory tragi. J Cutan Pathol (1990) 1.10
Inhibition of endogenous expression of connective tissue growth factor by its antisense oligonucleotide and antisense RNA suppresses proliferation and migration of vascular endothelial cells. J Biochem (1998) 1.09
Severe hypersensitivity to mosquito bites associated with natural killer cell lymphocytosis. Arch Dermatol (1990) 1.09
Establishment of the enzyme-linked immunosorbent assay for connective tissue growth factor (CTGF) and its detection in the sera of biliary atresia. Biochem Biophys Res Commun (1998) 1.08
Demonstration of receptors specific for connective tissue growth factor on a human chondrocytic cell line (HCS-2/8). Biochem Biophys Res Commun (1998) 1.06
Connective tissue growth factor as a major angiogenic agent that is induced by hypoxia in a human breast cancer cell line. Cancer Lett (2001) 1.06
Lipodystrophia centrifugalis abdominalis infantilis. Arch Dermatol (1971) 1.05
Monocyte-derived dendritic cells have a phenotype comparable to that of dermal dendritic cells and display ultrastructural granules distinct from Birbeck granules. J Leukoc Biol (1998) 1.05
Characterization of molecular defects in xeroderma pigmentosum group F in relation to its clinically mild symptoms. Hum Mol Genet (1998) 1.05
Prenatal nicotine exposure affects the development of the central serotonergic system as well as the dopaminergic system in rat offspring: involvement of route of drug administrations. Brain Res Dev Brain Res (1997) 1.05
Hypoxic regulation of stability of connective tissue growth factor/CCN2 mRNA by 3'-untranslated region interacting with a cellular protein in human chondrosarcoma cells. Oncogene (2006) 1.05
The Langerhans cell granule is an adsorptive endocytic organelle. J Invest Dermatol (1985) 1.04
Percutaneous peptide immunization via corneum barrier-disrupted murine skin for experimental tumor immunoprophylaxis. Proc Natl Acad Sci U S A (2000) 1.04
The incidence of internal malignancies in pemphigus and bullous pemphigoid in Japan. J Dermatol Sci (1995) 1.04
Expression of cadherin cell adhesion molecules during human skin development: morphogenesis of epidermis, hair follicles and eccrine sweat ducts. Arch Dermatol Res (1992) 1.04
Enzymatic determination of phospholipase D activity with choline oxidase. J Biochem (1978) 1.04
Recognition of YKL-39, a human cartilage related protein, as a target antigen in patients with rheumatoid arthritis. Ann Rheum Dis (2001) 1.03
Multiple cadherins are expressed in human fibroblasts. Biochem Biophys Res Commun (1997) 1.03
Bullous pemphigoid-like lesions induced by phenacetin. Report of a case and an immunopathologic study. Arch Dermatol (1984) 1.03
Gene alterations and clinical characteristics of xeroderma pigmentosum group A patients in Japan. Arch Dermatol (1994) 1.02
Kainic acid-induced dorsal and ventral hippocampal seizures in rats. Brain Res (2001) 1.02
Changes in parathyroid hormone receptors during chondrocyte cytodifferentiation. J Biol Chem (1994) 1.01
Evaluation of circulating immune complexes and antinuclear antibodies in Japanese patients with leprosy. Arch Dermatol Res (1983) 1.01
Ultrastructural observations of skin lesions in MRL mice--dermoepidermal junction. Arch Dermatol Res (1984) 1.01
Potassium iodide in the treatment of erythema nodosum and nodular vasculitis. Arch Dermatol (1981) 1.01
Geissoschizine methyl ether, an alkaloid in Uncaria hook, is a potent serotonin ₁A receptor agonist and candidate for amelioration of aggressiveness and sociality by yokukansan. Neuroscience (2012) 1.01
Anxiety accelerates T-helper 2-tilted immune responses in patients with atopic dermatitis. Br J Dermatol (2005) 1.00
Observation of EEG coherence after repetitive transcranial magnetic stimulation. Clin Neurophysiol (2000) 1.00
Involvement of CTGF, a hypertrophic chondrocyte-specific gene product, in tumor angiogenesis. Oncology (2001) 1.00
Shikonin, an ingredient of Lithospermum erythrorhizon, inhibits angiogenesis in vivo and in vitro. Anticancer Res (1998) 1.00
Expression of neurotrophins and their receptors (TRK) during fracture healing. Bone (2000) 1.00
Analysis of photosensitivity in Japanese cancer-bearing patients receiving photodynamic therapy with porfimer sodium (Photofrin). Photodermatol Photoimmunol Photomed (2001) 1.00
Potassium iodide in erythema nodosum and other erythematous dermatoses. J Am Acad Dermatol (1983) 1.00
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis. J Orofac Pain (2000) 0.99